Clinical Trial Update: Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of insulin glulisine in individuals with Type 1 diabetes mellitus; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Apidra (insulin glulisine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED